BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37022163)

  • 1. Reconstitution and Mutagenesis of Avian Infectious Laryngotracheitis Virus from Cosmid and Yeast Centromeric Plasmid Clones.
    Spatz S; García M; Fuchs W; Loncoman C; Volkening J; Ross T; Riblet S; Kim T; Likens N; Mettenleiter T
    J Virol; 2023 Apr; 97(4):e0140622. PubMed ID: 37022163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Diversity of Infectious Laryngotracheitis Virus during
    Loncoman CA; Hartley CA; Coppo MJC; Vaz PK; Diaz-Méndez A; Browning GF; García M; Spatz S; Devlin JM
    Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28939604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
    Helferich D; Veits J; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2007 Mar; 88(Pt 3):732-742. PubMed ID: 17325345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene.
    Han MG; Kweon CH; Mo IP; Kim SJ
    Arch Virol; 2002 May; 147(5):1017-31. PubMed ID: 12021870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.
    Loncoman CA; Hartley CA; Coppo MJ; Vaz PK; Diaz-Méndez A; Browning GF; Lee SW; Devlin JM
    PLoS One; 2017; 12(3):e0174590. PubMed ID: 28350819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture.
    Veits J; Mettenleiter TC; Fuchs W
    J Gen Virol; 2003 Jun; 84(Pt 6):1415-1425. PubMed ID: 12771409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of membrane proteins gD, gE, gI, and pUS9 of Infectious laryngotracheitis virus.
    Pavlova S; Veits J; Mettenleiter TC; Fuchs W
    Avian Dis; 2013 Jun; 57(2 Suppl):416-26. PubMed ID: 23901755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus.
    Schnitzlein WM; Winans R; Ellsworth S; Tripathy DN
    Virology; 1995 Jun; 209(2):304-14. PubMed ID: 7778265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor.
    Fuchs W; Ziemann K; Teifke JP; Werner O; Mettenleiter TC
    J Gen Virol; 2000 Mar; 81(Pt 3):627-38. PubMed ID: 10675400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked differences in virulence of three Australian field isolates of infectious laryngotracheitis virus in meat and layer chickens.
    Nazir S; Yegoraw AA; Charlesworth RPG; Williamson S; Sharpe S; Walkden-Brown SW; Gerber PF
    Avian Pathol; 2020 Dec; 49(6):600-610. PubMed ID: 32720515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of avian infectious laryngotracheitis virus.
    Fuchs W; Veits J; Helferich D; Granzow H; Teifke JP; Mettenleiter TC
    Vet Res; 2007; 38(2):261-79. PubMed ID: 17296156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein G is a virulence factor in infectious laryngotracheitis virus.
    Devlin JM; Browning GF; Hartley CA; Kirkpatrick NC; Mahmoudian A; Noormohammadi AH; Gilkerson JR
    J Gen Virol; 2006 Oct; 87(Pt 10):2839-2847. PubMed ID: 16963741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.